Trial intelligence / Profile preview

HUPSA: Humira treatment in psoriatic arthritis with imaging and biomarker assessment

2006-000004-16Phase 4Completed

Sponsor
Copenhagen University Hospital - Hvidovre
Start
Feb 2006
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 4, single-arm trial of adalimumab in psoriatic arthritis (PsA), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: PsARC response at week 24. Started Feb 2006; status: completed.

02

Drugs

03

Conditions

psoriatic arthritis (PsA)

Beyond the preview

Go deeper on 2006-000004-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-000004-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call